| 产品编号 | bs-8275R-PE-Cy5.5 |
| 英文名称 | Rabbit Anti-GPRIN1/PE-Cy5.5 Conjugated antibody |
| 中文名称 | PE-Cy5.5标记的G蛋白调节诱导神经突增生蛋白1抗体 |
| 别 名 | G protein regulated inducer of neurite outgrowth 1; GRIN1; KIAA1893; Z16; GRIN1_HUMAN. |
| 规格价格 | 100ul/2980元 购买 大包装/询价 |
| 说 明 书 | 100ul |
| 研究领域 | 细胞生物 免疫学 神经生物学 G蛋白信号 |
| 抗体来源 | Rabbit |
| 克隆类型 | Polyclonal |
| 交叉反应 | (predicted: Human, ) |
| 产品应用 | IF=1:50-200
not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
| 分 子 量 | 102kDa |
| 性 状 | Lyophilized or Liquid |
| 浓 度 | 1mg/ml |
| 免 疫 原 | KLH conjugated synthetic peptide derived from human GPRIN1 (131-170aa) |
| 亚 型 | IgG |
| 纯化方法 | affinity purified by Protein A |
| 储 存 液 | 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| 保存条件 | Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. |
| 产品介绍 |
background: GPRIN1 may be involved in neurite outgrowth. Function: May be involved in neurite outgrowth Subunit: Interacts with activated forms of GNAI1, GNAO1 and GNAZ Subcellular Location: Cell membrane; Lipid anchor. Cell projection growth cone. Note: Highly enriched in growth cone. Tissue Specificity: Widely expressed in the central nervous system, with highest levels in spinal cord. Post-translational modifications: Palmitoylation on Cys-999 and/or Cys-1000 is required for membrane targeting Database links: Entrez Gene: 114787 Human Omim: 611239 Human SwissProt: Q7Z2K8 Human Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| 1、抗体溶解方法 | |
| 2、抗体修复方式 | |
| 3、常用试剂的配制 | |
| 4、免疫组化操作步骤 | |
| 5、免疫组化问题解答 | |
| 6、Western Blotting 操作步骤 | |
| 7、Western Blotting 问题解答 | |
| 8、关于肽链的设计 | |
| 9、多肽的溶解与保存 | |
| 10、酶标抗体效价测定程序 | |
